Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Crimean-Congo Haemorrhagic Fever Vaccine (CCHFVaccine)

Start date: Jan 1, 2017, End date: Dec 31, 2022,

Natural epidemics and outbreaks of emerging viral epidemics are growing problems internationally. The general aim of the CCHFVaccine project is to develop and deliver a vaccine, which can significantly increase our capacity to control the situation of Crimean Congo Haemorrhagic fever (CCHF) disease on a global basis. The proposed work program on CCHF virus aims to build a multidisciplinary researc ...
Read Project

 15

 FINISHED 
Plasmodium vivax is the most widespread malaria and constitutes a significant proportion of human malaria cases. P. vivax accounts for 100-400 million clinical cases each year among the 2.5 billion people living at risk in Latin America, Oceania and Asia. The recently revised Malaria Vaccine Technology Roadmap to 2030 recognises the severity of P. vivax malaria and calls for a vaccine intervention ...
Read Project

 9

 FINISHED 

European Human Biomonitoring Initiative (HBM4EU)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Read Project

 43

 FINISHED 

Optimizing a deployable high efficacy malaria vaccine (OptiMalVax)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vaccine technologies and antigen discovery approaches now make accelerated design and development of a highly effective multi-antigen multi-stage subunit vaccine feasible. Leading malariologists, vaccine researchers and product developers will here collaborate in ...
Read Project

 17

 FINISHED 
ERA-HDHL is a proposal of ERA-NET Cofund in the field of nutrition and health to support the Joint Programme Initiative Healthy Diet for a Healthy Life (JPI HDHL).Nowadays, there is a high burden of non-communicable diseases due to unhealthy diet and lifestyle patterns. The 24 members of the JPI HDHL are working together to develop means to (1) motivate people to adopt healthier lifestyles includi ...
Read Project

 19

 FINISHED 
All chemicals whether they are drugs, cosmetics, agrochemicals or others need to be tested for their safety to man and the environment. The use of whole animal studies for the prediction of adverse effects in man, is problematic due to species dependent effects, high costs and a large burden to animals in terms of numbers and suffering. While there have been major improvements in human in vitro a ...
Read Project

 14

 FINISHED 
The proposed European Concerted Programme on Radiation Protection Research (acronym: CONCERT) aims to contribute to the sustainable integration of European and national research programmes in radiation protection. It will do so by focusing resources and efforts in five key directions:• Bring together the elements of the European scientific communities in the fields of radiation effects and risks, ...
Read Project

 36

 FINISHED 

Meaningful Integration of Data, Analytics and Services (MIDAS)

Start date: Nov 1, 2016, End date: Feb 29, 2020,

The MIDAS consortium is a partnership involving health authorities in five EU countries and the U.S. and technical big data experts from research institutions, MNCs and SMEs. Managing big data for ‘health in all’ is a monumental challenge for policy makers. MIDAS is addressing this challenge by developing and delivering an integrated solution which will liberate knowledge from data silos and unify ...
Read Project

 17

 FINISHED 
Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Influenza infections affect all age groups but children and adults over the age of 65 are at most risk of developing severe disease.Vaccination is the most effective approach to reduce the impact of annual influenza outbreaks and potential pandemics, however, the ...
Read Project

 26

 FINISHED 
Effective EU support to a large external crisis requires new approaches. In response to this challenge and to identified user and market needs from previous projects, Reaching Out proposes an innovative multi-disciplinary approach that will optimize the efforts, address a wide spectrum of users and maximize market innovation success.This approach results in five main objectives: to1. Develop a Col ...
Read Project

 29

 FINISHED 

Remotely Operated CBRNe Scene Assessment Forensic Examination (ROCSAFE)

Start date: Jul 1, 2016, End date: Jun 30, 2019,

The overall goal of ROCSAFE is to fundamentally change how CBRNe events are assessed, in order to and ensure the safety of crime scene investigators by reducing the need for them to enter high-risk scenes when they have to determine the nature of threats and gather forensics. For this, ROCSAFE will make use of cost-effective modern remotely-controlled robotic air and ground vehicles (RAVs/RGVs) th ...
Read Project

 14

 FINISHED 

European Virus Archive goes global (EVAg)

Start date: Apr 1, 2015, End date: Mar 31, 2019,

...mammalian viruses in the world and move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the world’s scientific community, including government health departments, higher education institutes, industry and, through information systems, the general public.
Read Project

 27

 FINISHED 

Eliciting Mucosal Immunity to Tuberculosis (EMI-TB)

Start date: Jan 1, 2015, End date: Dec 31, 2018,

Tuberculosis (TB) is a global health problem, killing 1.5 million of people every year. The only currently available vaccine, Mycobacterium bovis BCG, is effective against severe childhood forms, but it demonstrates a variable efficacy against the pulmonary form of TB in adults. Many of these adult TB cases result from the reactivation of an initially controlled, latent Mycobacterium tuberculosis ...
Read Project

 15

 FINISHED 
The EU population is increasingly exposed to new physical and chemical agents in the environment, some of which may be detrimental to public health. Of these, electromagnetic fields (EMF) are one of the most ubiquitous, with new EMF technologies and novel applications being actively developed and commercialised. To address pertinent questions on EMF and health, GERoNiMO proposes an integrated appr ...
Read Project

 27

 FINISHED 
The TBVAC2020 proposal builds on the highly successful and long-standing collaborations in subsequent EC-FP5-, FP6- and FP7-funded TB vaccine and biomarker projects, but also brings in a large number of new key partners from excellent laboratories from Europe, USA, Asia, Africa and Australia, many of which are global leaders in the TB field. This was initiated by launching an open call for Express ...
Read Project

 49

 FINISHED 
Smoking is the largest avoidable cause of preventable morbidity worldwide. It causes most of the cases of lung cancer and chronic obstructive pulmonary disease (COPD) and contributes to the development of other lung diseases. The control of smoking is considered as a highly important intervention for the prevention of lung diseases. Tobacco consumption is highly influenced by socioeconomic factors ...
Read Project

 14

 FINISHED 
Despite examples of excellent practice, rare disease (RD) research is still mainly fragmented by data and disease types. Individual efforts have little interoperability and almost no systematic connection between detailed clinical and genetic information, biomaterial availability or research/trial datasets. By developing robust mechanisms and standards for linking and exploiting these data, RD-Con ...
Read Project

 30

 FINISHED 
The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe. The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share val ...
Read Project

 33

 FINISHED 

MIND

Start date: Jul 31, 2015, End date: Aug 31, 2018,

Zowel in Duitsland als in Nederland is de Life Science & Health sector een innovatieve sector met veel groeipotentieel voor de toekomst. Daarbij heeft de zorg ook te maken met grote maatschappelijke uitdagingen. Denk bijvoorbeeld aan de vergrijzing en nieuwe ziektebeelden. In het Duits- Nederlandse grensgebied is veel kennis op het gebied van Life Science & Health. Er zijn in beide landen verschil ...
Read Project

 29

 FINISHED 
"For a vast amount of applications in the medical, industrial, research and other sectors, a good understanding of radiation protection (RP) is fundamental in order to protect workers, the public and the environment from the potential risks of ionising radiation. Within this perspective, building and maintaining an advanced level of competence in RP, assuring sufficient well-trained personnel and ...
Read Project

 14

 FINISHED 

Shaping EUROpean policies to promote HEALTH equitY (EURO-HEALTHY)

Start date: Jan 1, 2015, End date: Dec 31, 2017,

Health inequities have been increasing in Europe, particularly in a context of an ageing society and economic crisis. In countries with different levels of infrastructures and health system preparedness, inequities create significant policy challenges.The main goal of this project is to advance knowledge of policies that have the highest potential to enhance health and health equity across Europea ...
Read Project

 15

 FINISHED 
Sample return missions (SRMs) are a critical next step in our exploration of the Solar System and are identified as strategic missions by international space agencies. Europe has a very strong legacy in the curation and research of precious extraterrestrial materials. To maintain European leadership and ensure high-level involvement in future SRMs, a dedicated European Sample Curation Facility (ES ...
Read Project

 14

 FINISHED 
"As current influenza vaccines only afford limited protection against seasonal as well as pandemic influenza, and require regular updating, the development of a “universal” influenza vaccine that can provide broad coverage against different strains within a subtype or even across subtypes has become a key health care priority in both industrialized and low and middle income countries. EDUFLUVAC ai ...
Read Project

 9

 FINISHED 
Vitamin D deficiency has significant implications for human health and impacts on healthy growth and development and successful aging. Fundamental knowledge gaps are barriers to implementing a safe and effective public health strategy to prevent vitamin D deficiency and optimize status. ODIN will provide the evidence to prevent vitamin D deficiency in Europe and improve nutrition and public health ...
Read Project

 32

 FINISHED 
PANDHUB will create an integrated toolbox to aid transport operators and relevant actors in major transport hubs in the development of their current pandemic and dangerous pathogen preparedness and response plans. The project is intended to cover the extraordinary aspects specific to serious natural or man-made pathogen threats in the transport environment by providing accurate, reliable and valid ...
Read Project

 9

 FINISHED 
Drug development in TB requires new integrated methods to transition the novel combination regimens needed to shorten first-line therapy and combat multi-drug resistance. Although new agents are emerging, the path to registration of such regimens remains uncertain while capacity for pivotal trials is limited. Selection and optimization of drug combinations for development depends on preclinical sy ...
Read Project

 23

 FINISHED 

Advanced Immunization Technologies (ADITEC)

Start date: Oct 1, 2011, End date: Sep 30, 2017,

Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious diseases we need to fully exploit the potential of the human immune system. Progress in science and technology makes it possible to achieve what was previously deemed impossible. The scope of this project is to produce knowledge necessary to develop novel and ...
Read Project

 53

 FINISHED 

Universal Influenza Vaccines Secured (UNISEC)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

UNISEC brings together a European consortium of 3 University partners, 5 National Health Institutes and 3 SMEs, all with leading expertise in influenza vaccine research and development, to work on promising recently developed concepts for a universal influenza vaccine. The consortium is exceptionally strong, interdisciplinary and intersectional in nature, and encompasses a unique combination of sc ...
Read Project

 15

 FINISHED 

Innovation in teaching, training and dissemination of virology

Start date: Sep 1, 2014, End date: Aug 31, 2017,

Like viruses themselves, the scientific discipline of Virology has evolved from the study of viruses, to overlap and intertwine with many other scientific disciplines, both traditional and contemporary. As these developments into new areas of science such as gene therapy in treating cancers, reverse genetics in biotechnological assay development and nanotechnology in vaccine design continue to gr ...
Read Project

 8

 FINISHED 

Recognising Adverse Drug Reactions (WEB-RADR)

Start date: Sep 1, 2014, End date: Aug 31, 2017,

WEB-RADR is a consortium of leading experts in pharmacovigilance from regulatory agencies, research, academia and patient support groups. Together with EFPIA partners our aims will be to set policy & guidance and deliver robust information technology tools to address the potential for the reporting of adverse drug reactions (ADRs) through mobile applications and the recognition of drug safety sign ...
Read Project

 20

 FINISHED 

Global Research in Paediatrics (GRiP)

Start date: Jan 1, 2011, End date: Jun 30, 2017,

Paediatric drugs (PD) lack appropriate testing. Most drugs have inadequate information about dosing regimen, dose adjustment and how to administer them. These are longstanding problems that unquestionably require concerted efforts at the international level. Both the US and the EU have introduced paediatric legislation that facilitates participation of children in research and pharmaceutical innov ...
Read Project

 24

 FINISHED 
ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary ...
Read Project

 17

 FINISHED 

Getting Nursing Experience in a Different Health Care System

Start date: Jun 1, 2015, End date: May 31, 2017,

The idea of the project „Getting Nursing Experience in a Different Health Care System” is to give nursing trainees - during their initial vocational training at the “Fachschule für Gesundheits- und Krankenpflege der Katholischen Kliniken im Märkischen Kreis” - the chance to work in a different healthcare-system for a period of four weeks. With the “DHSS Education and Training Centre” (Douglas / Is ...
Read Project

 2

 FINISHED 

Open Project for the European Radiation Research Area (OPERRA)

Start date: Jun 1, 2013, End date: May 31, 2017,

"Within the OPERRA project, it is proposed that the MELODI Association, as a well-advanced network, takes the lead in establishing the necessary structures able to manage the long-term European research programmes in radiation protection, also taking advantage of the valuable experience gathered through the DoReMi network of excellence. Whilst in fields adjacent to low-dose risk research (radioeco ...
Read Project

 71

 FINISHED 

European Multicentre Tics in Children Studies (EMTICS)

Start date: Dec 1, 2011, End date: May 31, 2017,

This project will undertake pre-clinical and cohort studies that address susceptibility factors for paediatric and adolescent tic disorders, with a particular focus on comorbid obsessive-compulsive symptomatology, from clinical, epidemiological, genetic, microbiological and immunological angles. EMTICS aims to elucidate the complex aetiology of the onset and clinical course of chronic tic disorder ...
Read Project

 33

 FINISHED 
There exists a huge variety in the occurrence and characteristics of major incidents. Incident management stakeholders and in particular emergency health service providers have to deal with two basic challenges: The disproportion between the needs and the available human/material resources in the response capacity and the inherent time constraints of an emergency. These critical factors play a sem ...
Read Project

 12

 FINISHED 

Risk, Stem Cells and Tissue Kinetics – Ionising Radiation (RISK - IR)

Start date: Nov 1, 2012, End date: Apr 30, 2017,

The magnitude of cancer risk in humans exposed to low radiation doses (
Read Project

 16

 FINISHED 
Antibiotics are a mainstay of public health, but their use has increased exponentially leading to the emergence of antibiotic resistance. The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) project combines 5 international clinical studies, all supported by highly innovative microbiology, mathematical modelling and data-management, to determine - in the most rele ...
Read Project

 27

 FINISHED 
The innovative and economic potential of Manufactured Nano Materials (MNMs) is threatened by a limited understanding of the related EHS issues. While toxicity data is continuously becoming available, the relevance to regulators is often unclear or unproven. The shrinking time to market of new MNM drives the need for urgent action by regulators. NANoREG is the first FP7 project to deliver the answe ...
Read Project

 73

 FINISHED 
"ERANID, the European Area Network on Illicit Drugs, aims to improve cooperation in drug research in order to allow well-founded policy decisions.ERANID works both in the demand field and in the supply field. ERANID will promote multidisciplinary research activities in the field of socio-economic sciences and humanities. This may cover e.g. emerging drugs, vulnerable groups, changing demographics ...
Read Project

 13